Budesonide Teva 0.5 mg/ml sumutinsuspensio Ufini - Kifinlandi - Fimea (Suomen lääkevirasto)

budesonide teva 0.5 mg/ml sumutinsuspensio

teva pharma b.v. - budesonide - sumutinsuspensio - 0.5 mg/ml - budesonidi

Lecigon 20 mg/ml + 5 mg/ml + 20 mg/ml geeli suoleen Ufini - Kifinlandi - Fimea (Suomen lääkevirasto)

lecigon 20 mg/ml + 5 mg/ml + 20 mg/ml geeli suoleen

lobsor pharmaceuticals ab - carbidopa monohydrate, levodopa, entacapone - geeli suoleen - 20 mg/ml + 5 mg/ml + 20 mg/ml - levodopa

Trixeo Aerosphere Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

trixeo aerosphere

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Riltrava Aerosphere Umoja wa Ulaya - Kifinlandi - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.